"Compared with multivalent viral vaccines, we envision that a single protein-based antigen that protects against all three orthoebolavirus species that have caused previous outbreaks represents a more attractive alternative, which would be easier to manufacture and store than viral vaccines and could enable widespread vaccination strategies beyond ring vaccination."
#Immunology #Vaccine #Ebola

https://www.pnas.org/doi/10.1073/pnas.2316960121